Skip to main content
. 2018 Dec 19;23(12):3369. doi: 10.3390/molecules23123369

Table 2.

Inhibitory activity of 3-substituted-4-(quinoxalin-6-yl) pyrazoles 18ad, 19ad, 25a, 25b, 25d, 27b, and 27d against ALK5 and p38α MAP kinase.

graphic file with name molecules-23-03369-i002.jpg

Compounds R X IC50 (µM) Selectivity Index c
p38α a ALK5 b
18a H S >10 5.75 >2
18b o-F S >10 >10
18c m-F S >10 5.00 >2
18d m-CN S >10 >10
19a H S >10 0.57 >17
19b o-F S >10 0.28 >35
19c m-F S >10 0.33 >30
19d m-CN S >10 0.37 >27
25a H O >10 5.03 >2
25b o-F O >10 3.66 >3
25d m-CN O >10 4.12 >2
27b o-F S >10 >10
27d m-CN S >10 2.26 >4
3 (LY-2157299) 0.49 0.12 4

a p38α MAP kinase was expressed in E. coli as untagged human recombinant protein. The enzyme was purified by Ni-NTH–agarose (Qiagen). A proprietary radioisotopic protein kinase assay (33PanQinase® Activity Assay) was performed at ProQinase GmbH (Freiburg, Germany) using ATF2 as a substrate. b ALK5 was expressed in Sf9 insect cells as a human recombinant GST-fusion protein using the vaculovirus expression system. A proprietary radioisotopic protein kinase assay (33PanQinase® Activity Assay) was performed at ProQinase GmbH (Freiburg, Germany), using casein as a substrate. c IC50 of p38α/IC50 of ALK5.